4DMedical (ASX:4DX) said the operating revenue for year-to-date fiscal 2026 was AU$5 million, up 12% compared to the prior corresponding period, with gross margins exceeding 90%, according to a Thursday Australian bourse filing.

It reported operating revenue of AU$4.5 million in the prior-year period, according to a separate filing.

Receipts from customers in the fiscal third quarter ended March increased 18% year-over-year to AU$1.4 million, from AU$1.2 million.

Underlying software-as-a-service revenue was up 24% year-over-year for the nine months to March, driven by increased penetration across business-to-business software-as-a-service sites and distributors.